2022 M&A Healthcare Advisors Transactional Outlook Part Two: Pharmacy

M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy.

Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.

“Specialty pharmacy valuations have remained stable in recent years in spite of downward pressure on sales, gross margin and net income,” Ulloa said.

While certain segments of the pharmacy market remain strong, not all of them have fared as well recently.

“Long-term care pharmacies have experienced one of the steepest valuation declines in recent years as a result of COVID and home-based care,” Ulloa noted.

For more insight into the healthcare business market, follow the latest from M&A Healthcare Advisors here.

Follow us on social media for the latest updates in B2B!


Forging Connections: Flipping CAPA on It’s Head with Prevention
October 4, 2022
Waste and lost money run rampant in various sectors, and healthcare and pharmaceuticals are no exception. Bethany Kearney, Director of Enablement for Sparta Systems, and Zillery Fortner, Product Read more
E2B: Energy to Business: Why Threat of Rail Strike Heightened Supply Chain Issues
October 4, 2022
  Freight rail is a critical mode of logistics and transportation for moving products throughout the supply chain. So, when the recent threat of a rail strike nearly derailed the supply chain and cost the Read more
Better Broadband: IoT and Connectivity as a Service
October 4, 2022
 In early July 2022, nearly a quarter of the Canadian population was disconnected after a significant network went down. The outage impacted emergency services, banks, hospitals, and nearly every Read more